Chenopodium

Chenopodium: A Comprehensive Encyclopedic Reference

1. Identity: Botanical Classification, Nomenclature, and Natural Sources

Chenopodium is a genus of numerous species of perennial or annual herbaceous flowering plants known as the goosefoot, which occur almost anywhere in the world. It is placed in the family Amaranthaceae in the APG II system; older classification systems, notably the widely used Cronquist system, separate it and its relatives as Chenopodiaceae. Among the Amaranthaceae, the genus Chenopodium is the namesake member of the subfamily Chenopodioideae.

The genus Chenopodium was described by Carl Linnaeus in 1753 (In: Species Plantarum, Vol. 1, p. 218–222). The type species is Chenopodium album. This generic name is derived from the particular shape of the leaf, which is similar to a goose's foot: from Greek χήν (chen), "goose" and πούς (pous), "foot" or ποδίον (podion), "little foot." In its traditional circumscription, Chenopodium comprised about 170 species.

Phylogenetic research revealed that the genus was highly polyphyletic and did not reflect how species were naturally related. Therefore, a new classification was necessary. Mosyakin & Clemants (2002, 2008) separated the glandular species as genus Dysphania (which includes epazote) and Teloxys in tribe Dysphanieae. Modern molecular studies recognize six independent lineages: Chenopodium s.s. (the largest and most diverse clade), Blitum L., Chenopodiastrum S. Fuentes, Uotila & Borsch, Dysphania R.Br., Lipandra Moq., and Oxybasis Kar. & Kir.

The following species are of principal medicinal and nutritional significance and are treated in this article:

• Chenopodium album L. — common lambsquarters, white goosefoot, fat hen; bathua (Hindi). The primary species discussed in the pharmaceutical literature.
• Dysphania ambrosioides (L.) Mosyakin & Clemants (syn. Chenopodium ambrosioides L.) — epazote, wormseed, Mexican tea. Reclassified into Dysphania but historically and commercially referred to as "Chenopodium."
• Chenopodium quinoa Willd. — quinoa. A nutritional pseudocereal crop widely studied for its protein and micronutrient content.
• Chenopodium formosanum Koidz. — djulis. A Taiwanese cereal grain species with emerging research on antidiabetic properties.

Chenopodium album (common lambsquarters, white goosefoot) is a globally distributed and economically important species. The taxon C. album is a species aggregate consisting of wild and cultivated forms, reflecting its history of multiple interactions with human agriculture. In addition to variable morphotypes, multiple ploidy levels have been identified within this aggregate.

C. album can be found practically anywhere in nitrogen-rich soils and grows between 20 cm and 1.5 m in height. The species of Chenopodium (s.str.) are annual or perennial herbs, shrubs or small trees. The young stems and leaves are often densely covered by vesicular globose hairs, thus looking farinose (mealy-white).

Common Forms and Preparations

Several bioactive compounds have been isolated from the seeds, leaves, and roots of Chenopodium species. Chenopodium species have been cultivated as a vegetable and subsidiary grain crop for centuries due to their protein and amino acid contents. Today, C. quinoa Willd. and C. album L. are still significant sources of pseudocereals. Preparations encountered in traditional and contemporary contexts include:

• Fresh or cooked leaves and shoots: consumed as leafy vegetables, in soups, stews, and stir-fries.
• Decoctions and infusions: Infusions and decoctions of the leaves, roots, and inflorescences have been used for centuries as dietary condiments and as traditional anthelmintics by native peoples for the treatment of intestinal worms.
• Essential oil (oil of chenopodium): Commercial preparations of oil of chenopodium and its active constituent ascaridole, obtained by steam distillation, have been and continue to be used with considerable success.
• Standardised plant extracts: Ethanolic, methanolic, aqueous, and chloroform extracts are the primary forms used in laboratory research, prepared using Soxhlet apparatus or maceration.
• Dried powdered herb: Encapsulated or used as loose powder; also explored for incorporation into food products.
• Seed flour/powder: Particularly for C. quinoa and C. album, explored as a nutraceutical ingredient.

2. Traditional and Historical Use

South Asian (Ayurvedic and Folk) Traditions

Chenopodium species have been documented in ancient Indian texts such as Ayurveda, Atharva Veda, Charak Samhita, and Sushruta Samhita, highlighting their repository of medicinal properties. The leaves of Chenopodium album, known as bathua sag in Hindi and pigweed in English, are distributed throughout the world, with about 21 species occurring in India, particularly in Western Rajasthan, Kulu Valley, and Shimla.

In traditional Indian medicine, hemorrhoids and gastroenteritis have been treated using the entire plant, either cooked by itself or in combination with other herbs. Additionally, it has been employed as a diuretic, depurative, and antianemic. It is also a traditional leafy vegetable in India. C. album is conventionally used as anthelmintic, cardiotonic, carminative, digestive, diuretic, and laxative. It is widely used in the treatment of peptic ulcer, dyspepsia, flatulence, strangury, pharyngopathy, splenopathy, ophthalmopathy, and general debility. Traditionally, C. album is used for the cure of hepatic disorders, spleen enlargement, intestinal ulcers, and burns.

Mesoamerican and South American Traditions

Chenopodium ambrosioides L., originating from Central America, has attracted considerable attention for its historical use across various cultures. It has been employed as an anti-helminthic, anti-inflammatory, anti-tumoral, and wound-healing agent, particularly noted for its traditional use in treating Leishmania-induced skin ulcers. From pre-Hispanic times, when it was part of the diet and pharmacopoeia of the Mayans, Aztecs, and other indigenous peoples, epazote stands out for its properties, versatility, and abundant availability in diverse ecosystems. Ethnopharmacological studies in a community of Mayan subsistence farmers in Chiapas, Mexico, confirmed that decoctions containing up to 300 mg of dry plant material per kg body weight were widely used and traditionally highly regarded in the treatment of ascariasis.

General Ethnomedicinal Use Across Cultures

Findings prove the traditional importance of Chenopodium album in the international traditional pharmacopoeia and show that its traditional use differs according to several aspects, including geographical region, ethnic group, part used, and preparation methods. The herb has been found to be applied traditionally for many health disorders ranging from digestive abnormalities to eye defects, throat-related disorders, diseases of the blood, and problems of the spleen and liver. Leaves are used to treat kidney and urinary tract disorders, to purify blood, to protect people from contracting roundworms and hookworms (anthelmintic), to induce laxation, and to treat liver diseases, splenomegaly, burns, and intestinal ulcers.

Archaeological evidence points to the prehistoric cultivation of Chenopodium as a pseudocereal in Europe. The plant has been consumed as an important food source since antiquity, with leaves and tender twigs consumed as vegetables.

3. Key Constituents and Active Compounds

Primary Phytochemical Classes

Apart from the appreciable composition of carbohydrates, protein, and fats, other phytochemicals belonging to the class of alkaloids, saponins, terpenoids, flavonoids, and phenolic compounds make C. album a versatile revitalizing source. C. album has many active compounds, such as trypsin inhibitors (0.11–0.17 TIU/mg), proteins (28.69%), phenols (224.99–304.98 mg GAE/100 g), saponins (0.043–0.867 g/100 g), flavonoids (220.0–406.67 mg/100 g), phytic acid (238.3–268.33 mg/100 g), tannins (152.49–203.91 mg GAE/100 g), alkaloids (1.27–1.53 mg/100 g), oxalates (394.19–477.08 mg/100 g), oils, and trace elements.

Flavonoids

The most important flavonoids contained in C. album consist of 3-O-glycosides of kaempferol, quercetin, and isorhamnetin. Chenopodium album also contains phenolic amide. The three major flavonoids isolated from Chenopodium album are quercetin, rutin, and kaempferol.

Alkaloids, Saponins, and Other Secondary Metabolites

Several compounds including apocarotenoids, saponin, alkaloid chenoalbicin, and cinnamic acid amide, alongside phenols and lignans, have been identified in C. album. Chenopodium album has flavonoids like phenolic amide, which has hypotensive properties.

Essential Oil Constituents and Ascaridole

The chief phytochemical compounds reported in the plant belong to the class of alkaloids, flavonoids, steroids, and saponins. In addition, the oil obtained by hydro-distillation of leaves has been found to contain p-cymene and the anthelmintic compound ascaridole. The aerial plant parts of C. ambrosioides contain essential oil (0.7% in the leaves, 2.5% in the unripe fruits), which is composed of various monoterpenoids (α-pinene, α-phellandrene, thymol, myrcene, p-cymene, terpinene, camphor, trans-isocarveol) and ascaridole, a monoterpenoid peroxide.

Nutritional Macro- and Micronutrients

The high protein content and a balanced spectrum of amino acids are among the fascinating features of the plant; leucine, lysine, and isoleucine are the predominant amino acids present in the leaves. The vitamin and mineral composition of the plant includes retinoic acid, ascorbic acid, thiamine, riboflavin, niacin, potassium, magnesium, calcium, iron, phosphorous, and traces of pantothenic acid. Chenopodium album contains ascorbic acid, β-carotene, iron (12–250 ppm), tryptophan, and tyrosine, but also toxic oxalates, oxalic acid, and nitrate.

Mechanisms of Action

The redox properties of phenolic compounds allow them to serve as hydrogen donors, reducing agents, and singlet oxygen quenchers, thus turning them into antioxidants. They are also shown to be potent antioxidants capable of stopping or slowing the pace of oxidation, a free radical chain reaction that occurs in materials susceptible to oxidation. Phenolic compounds in the plant are responsible for several biological activities, including anticancer, antihyperglycemic, anti-inflammatory, antimicrobial, and lowering of adipogenesis. The high content of crude alkaloids is responsible for the spasmolytic and anesthetic activity. The antidiabetic effect of Chenopodium album extracts may be due to the presence of glycosides, flavonoids, and phenolic constituents.

Saponins and flavonoids from certain Chenopodium species (C. foliosum, C. bonus-henricus) demonstrated significant neuroprotective and antioxidant activities across models of induced oxidative stress, including 6-OHDA, t-BuOOH, and Fe²⁺/AA-induced lipid peroxidation. The plausible mechanisms of neuroprotection rely on MAO-B inhibition, the scavenging of ROS, stabilizing the cell membrane by reducing MDA production, and neutralizing free radicals by maintaining GSH levels.

4. Scientific Evidence by Area of Use

The overwhelming majority of evidence for Chenopodium's pharmacological activities is preclinical — derived from in vitro assays and animal experiments. As of the time of writing, no large, well-controlled randomized clinical trials in humans have been published establishing therapeutic efficacy for any indication. The following section summarizes the available literature with an explicit characterization of study type and strength.

4.1 Antioxidant Activity

Evidence strength: Moderate (consistent in vitro and animal data; no human RCTs).

The potential anti-inflammatory and anti-arthritic activities of C. album have been investigated, together with its antioxidant potential. The phytochemical composition was assessed by means of GC-MS and HPTLC. The antioxidant properties were assessed using the DPPH and β-carotene bleaching test. The ability of extracts to protect against lipid peroxidation was also examined in rat-liver microsomal membranes.

Across solvent-specific extraction studies, the water extract of C. album exhibited no antimicrobial effect, whereas the methanol extract created the highest zone diameter on Bacillus cereus (26 mm). The methanol extract displayed the highest activity in DPPH and ABTS antioxidant assays. The ethanol extract yielded the highest reducing power in the CUPRAC assay. The water extract had the highest reducing power in the FRAP assay. These results illustrate that antioxidant potency in C. album is strongly dependent on the extraction solvent, making direct comparisons between studies difficult.

4.2 Antimicrobial Activity

Evidence strength: Preliminary (in vitro only; no clinical human data).

Various concentrations ranging from 100 to 500 μg/ml of the extract were subjected to antimicrobial screening by disc diffusion method against four selected bacterial strains (Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas multocida, and Escherichia coli) and two fungal strains (Aspergillus flavus and Candida albicans). The extract showed maximum inhibitory effect against S. aureus (28 ± 0.14 mm), while a mild inhibitory effect was observed against E. coli among the selected microbial strains. The effect produced by the different extract concentrations was comparable with the standard antibacterial agent streptomycin sulphate and antifungal agent nystatin, which were used as effective positive controls.

This species notably exhibits various biological activities including antibacterial, antifungal, and antioxidant effects. However, toxicological investigations and pharmacokinetic validation are necessary in order to identify possible toxicity. All available antimicrobial data are from in vitro models; translation to human clinical benefit has not been demonstrated.

4.3 Anthelmintic (Anti-Parasitic) Activity

Evidence strength: Preliminary to moderate for animal parasites (in vitro and in vivo animal data); limited and inconclusive for human parasites.

The objective of one study was to evaluate the anthelmintic, antimicrobial, and antioxidant activities of Chenopodium album against gastrointestinal nematodes of sheep and some pathogenic microbes. A worm motility inhibition assay was used for the in vitro study, and a faecal egg count reduction assay was used for the in vivo study. The extracts exhibited dose- and time-dependent anthelmintic effects on Haemonchus contortus as compared to levamisole.

Ascaridole, an important phytoconstituent present in aerial parts of the plant, contributes to its anthelmintic property. For C. ambrosioides, ethnopharmacological studies in a community of Mayan subsistence farmers in Chiapas, Mexico, confirmed that decoctions containing up to 300 mg of dry plant material per kg body weight were widely used and traditionally highly regarded in the treatment of ascariasis. However, therapeutic doses of up to 6000 mg/kg body weight of powdered, dried plant had no significant anthelmintic effect on the adults of Necator, Trichuris, or Ascaris in clinical field trials. This finding underscores the gap between traditional use and clinically demonstrated efficacy.

4.4 Hepatoprotective Activity

Evidence strength: Preliminary (animal models only; no human clinical trials).

A study exploring the protective effect of the methanolic extract of Chenopodium album against carbon tetrachloride (CCl4)-induced hepatotoxicity in rats used thirty Wistar (albino) rats (150–200 g), divided into six groups. Methanolic extract of C. album (whole plant) was prepared with a Soxhlet extractor and rotatory evaporator. Antioxidant activity was determined by DPPH free radical scavenging assay. Chenopodium album minimized the levels of ALT (70 ± 8.68 U/L, 68.75 ± 8.38 U/L, and 73.5 ± 10.28 U/L), AST (219.5 ± 19.16 U/L, 140.75 ± 13.35 U/L, and 221.25 ± 13.33 U/L), and ALP (289.5 ± 28.21 U/L, 258 ± 11.12 U/L, and 248.25 ± 4.03 U/L) at different concentrations (100 mg/kg, 200 mg/kg, 300 mg/kg respectively). These are preclinical findings only, and hepatoprotective effects in humans have not been established.

4.5 Anti-inflammatory and Antirheumatic Activity

Evidence strength: Preliminary (in vitro and animal models; no human RCTs).

The anti-rheumatic potential of C. album was already investigated by Arora and coworkers, who tested the acetone extract of aerial parts on complete Freund's adjuvant-induced rheumatoid arthritis in rats. Several studies have shown the anti-inflammatory properties of C. album on different in vitro and in vivo models, and the antinociceptive activity has also been the subject of multiple studies in different parts of this species. C. album can also act as a spasmolytic and analgesic, antidiabetic and antihyperlipidemic, antipruritic, anticholinesterase, anti-butyrylcholinesterase, anti-ulcer, antiparasitic, antirheumatic, and anti-Helicobacter pylori. These activities have been reported in preclinical systems.

4.6 Antidiabetic Activity

Evidence strength: Preliminary (animal studies only for C. album; one small human study for related C. formosanum).

C. album is ethnobotanically used in several parts of the world for its potent antidiabetic activity. A study emphasized the antidiabetic potential of methanolic extract of the plant in male Wistar albino rat models. Treatment with a high dose of C. album extract (500 mg/kg body weight, p.o.) resulted in the maximum decrease in fasting blood glucose level (139.5 ± 4.8 mg/dL, p < 0.01), while mild and low doses caused a slower reduction (142.2 ± 4.1 mg/dL and 148.3 ± 1.5 mg/dL, p < 0.01 respectively).

Regarding the related species Chenopodium formosanum (djulis), a human study was conducted: The study investigated the in vivo antidiabetic effect on patients with type 2 diabetes mellitus (T2DM) after consuming djulis hull powder. Djulis hull contained dietary fibre 75.21 ± 0.17% dry weight, and insoluble dietary fibre (IDF) reached 71.54 ± 0.27% dry weight. The IDF postponed the adsorption of glucose and reduced the activity of α-amylase. Postprandial blood glucose levels in patients with T2DM showed different tendencies. After consuming 10 g or 5 g djulis hull powder before 75 g glucose, patients with T2DM had blood glucose values that were significantly lower at the same postprandial times than those of patients who did not consume djulis hull. Djulis hull may have benefits for patients with T2DM. This study is notable for being one of the few involving human subjects within the genus; however, it should not be extrapolated directly to C. album, which is a different species.

4.7 Anticancer Activity

Evidence strength: Very preliminary (in vitro cell-line studies only; no animal or human evidence).

Studies have investigated the effects of Chenopodium album leaves on the growth of estrogen-dependent (MCF-7) and estrogen-independent (MDA-MB-468) human breast cancer cell lines. The methanol extract exhibited significant percent inhibition (94.06%) at 48 h of exposure at the concentration 100 mg/mL using MTT bioassay. Further, C. album showed anti-cancer activity against breast cancer, gastric cancer, and Ehrlich ascites carcinoma. All of these findings are derived from cell-culture or animal experiments and do not constitute clinical evidence of anticancer activity in humans.

4.8 Nephroprotective Activity

Evidence strength: Preliminary (animal models; no human clinical trials).

Phytocomponents such as phenolic compounds and flavonoids are responsible for antioxidant properties and have nephroprotective properties, making medicinal plants a great potential source for pharmaceutical products. In a rat study examining the effects on gentamicin-induced nephrotoxicity, extracts of C. album aerial parts were obtained from ethanol, water, methanol, chloroform, and hexane solvents. Thirty-two male Wistar albino rats were used and gentamicin-induced nephrotoxicity was utilised as a model. These results remain exclusively preclinical.

4.9 Neuroprotective Activity

Evidence strength: Very preliminary (in vitro studies with rat brain fractions; no animal or human data).

Research has investigated 15 flavonoids and saponins from C. foliosum and C. bonus-henricus for their inhibitory activity against human monoamine oxidase-A and -B (hMAO-A/B). Active compounds were examined in various subcellular fractions of the rat brain, including synaptosomes, mitochondria, and microsomes. These findings are exploratory and have not been validated in clinical settings.

5. Body Systems and Health Areas of Association

C. album has been utilised for several disease-modifying and health-promoting activities in the cardiovascular, circulatory, digestive, and immune systems. Based on the collated research, the following body system associations have been investigated:

• Digestive system: Anthelmintic, antidiarrheal, gastroprotective, anti-ulcer, and laxative properties; traditional use for hemorrhoids, gastroenteritis, flatulence, and intestinal parasites.
• Hepatic system: Hepatoprotective potential assessed in CCl4 and alcohol-induced liver damage models in rodents.
• Immune and inflammatory system: Anti-inflammatory and antinociceptive activities in rodent arthritis and pain models.
• Endocrine/metabolic system: Antidiabetic activity in streptozotocin- and alloxan-induced diabetic animal models; antihyperlipidemic effects investigated.
• Renal system: Nephroprotective effects examined in gentamicin-induced nephrotoxicity models; also associated with treatment of kidney stones and urinary tract disorders in traditional practice.
• Hematopoietic system: Traditional use as a blood purifier and antianemic, consistent with the plant's high iron and folate content.
• Oncology (investigational): In vitro cytotoxic activity against breast, gastric, and Ehrlich carcinoma cell lines; no clinical evidence.
• Nervous system (exploratory): MAO inhibition and neuroprotective activities documented in vitro for select species.

6. Dosage Forms and Dosages Reported in Studies

No standardized therapeutic dose for Chenopodium album or related species has been established by any major pharmacopeial authority. The following dosages appear only in the context of experimental or preclinical research as reported in the cited literature, and are not treatment recommendations.

• Hepatoprotective (animal, rat model): Chenopodium album methanolic extract was tested at 100 mg/kg, 200 mg/kg, and 300 mg/kg body weight by oral gavage in Wistar albino rats, showing minimization of liver enzyme levels (ALT, AST, ALP) at each dose level.
• Antidiabetic (animal, rat model): A high dose of C. album extract at 500 mg/kg body weight (p.o.) resulted in the maximum decrease in fasting blood glucose levels; mild and low doses caused a slower reduction.
• Antimicrobial (in vitro): Various concentrations ranging from 100 to 500 μg/ml of the extract were subjected to antimicrobial screening by disc diffusion method against selected bacterial and fungal strains.
• Anthelmintic field study (C. ambrosioides, human ethnopharmacological): Decoctions containing up to 300 mg of dry plant material per kg body weight were widely used and traditionally highly regarded in the treatment of ascariasis.
• Antidiabetic (C. formosanum djulis hull, human study): The area under the glucose curve was significantly lower after ingesting 10 g or 5 g djulis hull powder before 75 g glucose, compared with patients who did not consume djulis hull.
• Anticancer (in vitro): Methanol extract exhibited significant percent inhibition (94.06%) at 48 h of exposure at the concentration 100 mg/mL against MCF-7 breast cancer cells using MTT bioassay.
• Toxicology (acute oral, rat): At doses of 2000 mg/kg body weight, no notable sign of organ toxicity was observed by histopathological analysis, although mild toxicity in the liver, kidney, and heart was observed. Acute oral toxicity studies of different doses of C. album alcoholic and aqueous extracts revealed the safety of extracts up to the 5000 mg/kg dose level.

While some small-scale clinical studies have investigated the effects of Chenopodium extracts on human health, results remain preliminary and larger, well-controlled trials are necessary for conclusive evidence of specific health benefits.

7. Safety Considerations and Interactions

Antinutrients: Oxalates and Phytic Acid

Plants in the Chenopodiaceae family are well known to contain high levels of oxalates. Oxalate is not an essential nutrient for humans and, if possible, it should not be consumed in large amounts. If consumed in large amounts, oxalates may be harmful to human health. The percentage of insoluble calcium in the total calcium was significantly reduced when leaves were boiled, but the insoluble oxalate content significantly increased (67.2%) in wok-fried leaves when compared to the content of the original raw leaves. This finding has important practical significance: boiling appears to reduce bioavailable oxalate, whereas wok-frying may increase it.

Nitrate Content

Chenopodium album contains, among other compounds, toxic oxalates, oxalic acid, and nitrate. A case of nitrate poisoning in cattle fed Chenopodium album hay has been reported in the veterinary literature (Ozmen O, Mor F, and Ayhan U, 2003, as cited in the research record), highlighting that nitrate accumulation in the plant can pose a risk under certain conditions, particularly in ruminant animals and potentially at very high human consumption levels.

Reported Case of Renal Toxicity

A 68-year-old female patient used Chenopodium album for weight loss and experienced impaired kidney function, and was diagnosed with acute tubulointerstitial nephritis (ATIN) following a biopsy. Its popularity is increasing due to the belief that it has fewer side effects compared to synthetic drugs. However, its use can lead to acute or chronic poisoning. The growing interest in herbal remedies, along with uncontrolled usage and disregard for expert recommendations, contributes to adverse effects. The patient responded positively to corticosteroid and hemodialysis treatment. This published case report is a notable safety signal warranting further investigation.

Toxicity of Essential Oil (C. ambrosioides)

The essential oil of C. ambrosioides (epazote) can be toxic in high doses, especially in children, pregnant women, or people with kidney problems. The principal constituent ascaridole is a reactive monoterpenoid peroxide responsible for both the anthelmintic effect and part of the toxicological profile.

Trypsin Inhibitors and Antinutrients

C. album contains trypsin inhibitors at levels of 0.11–0.17 TIU/mg, which can interfere with protein digestion when the plant is consumed raw or inadequately processed. Although a high dose of phytoconstituents in concentrated form is usually not consumed and also not available in diet fractions, its safety in high doses needs to be investigated.

Pollen Allergenicity

Chenopodium pollen is a documented environmental allergen. Individuals sensitized to Chenopodium pollen may, on theoretical grounds, exhibit cross-reactivity to preparations from the plant itself, although this has not been extensively studied in the context of ingested supplements.

Processing Effects

Blanching and drying could be a possible way towards the removal of antinutrients from C. album preparations. Processing methods such as boiling are routinely employed in cultures where the plant is consumed as a vegetable, and these methods reduce the burden of heat-labile antinutrients.

Overall Safety Assessment

This review proves the necessity of breakthrough research to investigate the pharmacology and safety of phytochemicals and nutraceutical development studies on the C. album. Toxicological investigations and pharmacokinetic validation are necessary in order to identify possible toxicity of this species. The available evidence base does not allow definitive conclusions about safe therapeutic doses for human use.

8. Summary of Evidence Quality

The scientific literature on Chenopodium, primarily C. album, as a medicinal or dietary supplement ingredient is extensive in breadth but uniformly preliminary in depth. Despite its traditional use since historical times, the plant has not undergone any research studies of renowned character, which represents the need for intensive exploration of the plant. This body of research proves the necessity of breakthrough research to investigate the pharmacology and safety of phytochemicals and nutraceutical development studies on C. album.

Virtually all pharmacological claims for C. album rest on in vitro assays and small rodent experiments. The single area where a human study exists within the genus is the antidiabetic work on C. formosanum (djulis), which cannot be directly extrapolated to other species. Traditional anthelmintic use of C. ambrosioides was not confirmed in at least one clinical field trial. Results remain preliminary and larger, well-controlled trials are necessary for conclusive evidence of specific health benefits.

References

• Wikipedia: Chenopodium (genus overview, taxonomy, and nomenclature)
• PMC (NCBI): A Compiled Update on Nutrition, Phytochemicals, Processing Effects, Analytical Testing and Health Effects of Chenopodium album: A Non-Conventional Edible Plant (NCEP)
• PMC (NCBI): Investigation of antimicrobial and antioxidant activities of Chenopodium album extracts and their effects on gentamicin nephrotoxicity in rats
• PMC (NCBI): Chenopodium album extract ameliorates carbon tetrachloride induced hepatotoxicity in rat model
• PMC (NCBI): Chenopodium album L. and Sisymbrium officinale (L.) Scop.: Phytochemical Content and In Vitro Antioxidant and Anti-Inflammatory Potential
• PMC (NCBI): Chenopodium album prevents progression of cell growth and enhances cell toxicity in human breast cancer cell lines
• PMC (NCBI): Ameliorating potency of Chenopodium album Linn. and vitamin C against mercuric chloride-induced oxidative stress in testes of Sprague Dawley rats
• PMC (NCBI): Flavonoids and Saponins from Two Chenopodium Species (C. foliosum Asch. and C. bonus-henricus L.) — Preliminary Evaluation for hMAO-A/B, Neuroprotective Activity
• PMC (NCBI): Oxalate Contents of Raw, Boiled, Wok-Fried and Pesto and Juice Made from Fat Hen (Chenopodium album) Leaves
• PMC (NCBI): A case of acute tubulointerstitial nephritis following the use of Chenopodium album L.
• PMC (NCBI): Functionality of Djulis (Chenopodium formosanum) By-Products and In Vivo Anti-Diabetes Effect in Type 2 Diabetes Mellitus Patients
• PMC (NCBI): Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
• PubMed: Evaluation of anthelmintic antimicrobial and antioxidant activity of Chenopodium album (Lone et al., Tropical Animal Health and Production, 2017)
• PubMed: Studies on the traditional herbal anthelmintic Chenopodium ambrosioides L.: ethnopharmacological evaluation and clinical field trials
• PubMed: Chemical Diversity and Health-Promoting Attributes of Chenopodium album: Nutritional and Pharmacological Perspectives (Majumdar et al., Chemistry & Biodiversity, 2025)
• ScienceDirect: Genetic diversity, antimicrobial, nutritional, and phytochemical properties of Chenopodium album: A comprehensive review
• ScienceDirect: Nutritional value and therapeutic applications of Chenopodium album for human and livestock health: A comprehensive review (2025)
• ScienceDirect Topics: Chenopodium (overview)
• PLOS ONE: Fruit and Seed Anatomy of Chenopodium and Related Genera (Chenopodioideae, Chenopodiaceae/Amaranthaceae): Implications for Evolution and Taxonomy
• IJHER (Thieme): Chenopodium album: Exploring the Therapeutic Values of the Plant
• MDPI Plants: Chenopodium album L. and Sisymbrium officinale (L.) Scop.: Phytochemical Content and In Vitro Antioxidant and Anti-Inflammatory Potential